Profile
Daniela Carmen Oniciu is the founder of Creative Pharma Advisors LLC.
She worked as an Associate Director-Chemistry at Pfizer Inc. from 2004 to 2008.
Prior to that, she was a Senior Director-Chemical Research & Development at Esperion Therapeutics, Inc. from 2001 to 2004.
From 2005 to 2014, she held the position of Senior Director-Chemistry at ABIONYX Pharma SA. Later, she served as the Vice President-Preclinical Research & Development at Gemphire Therapeutics, Inc. from 2014 to 2018.
In addition to her former jobs, she also worked as the Chief Operating Officer at BioSavita, Inc. and as the Head-Research & Development at Ocuphire Pharma, Inc. Dr. Oniciu obtained her graduate and doctorate degrees from Politehnica University of Bucharest.
Former positions of Daniela Oniciu
| Companies | Position | End |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2023-12-30 |
| NEUROBO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2018-10-31 |
| ABIONYX PHARMA | Corporate Officer/Principal | 2014-01-31 |
| PFIZER, INC. | Corporate Officer/Principal | 2008-01-31 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 2003-12-31 |
Training of Daniela Oniciu
| Politehnica University of Bucharest | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
BioSavita, Inc.
 BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Health Technology |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
| Creative Pharma Advisors LLC |
- Stock Market
- Insiders
- Daniela Oniciu
